Axsome Therapeutics Inc banner

Axsome Therapeutics Inc
F:19X

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
F:19X
Watchlist
Price: 209.8 EUR -0.47% Market Closed
Market Cap: €10B

Wall St Price Targets

19X Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast 19X stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 19X is 127.24 EUR with a low forecast of 94.25 EUR and a high forecast of 151.88 EUR.

Lowest Forecast
Price Target
94.25 EUR
55% Downside
Average Forecast
Price Target
127.24 EUR
39% Downside
Highest Forecast
Price Target
151.88 EUR
28% Downside
Axsome Therapeutics Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 55%.

Gross Profit
Forecast

N/A
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Gross Profit over the next 3 years is 51%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 19X's stock price target?
Price Target
127.24 EUR

According to Wall Street analysts, the average 1-year price target for 19X is 127.24 EUR with a low forecast of 94.25 EUR and a high forecast of 151.88 EUR.

What is the Revenue forecast for Axsome Therapeutics Inc?
Projected CAGR
55%

The compound annual growth rate for Revenue over the next 3 years is 55%.

What is the Gross Profit forecast for Axsome Therapeutics Inc?
Projected CAGR
51%

The compound annual growth rate for Gross Profit over the next 3 years is 51%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett